These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22777043)

  • 1. Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.
    Bowler LL; Zhanel GG; Ball TB; Saward LL
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4976-9. PubMed ID: 22777043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms.
    Hengzhuang W; Ciofu O; Yang L; Wu H; Song Z; Oliver A; Høiby N
    Antimicrob Agents Chemother; 2013 Jan; 57(1):196-204. PubMed ID: 23089750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenemase-producing Pseudomonas aeruginosa in UK.
    Woodford N; Palepou MF; Babini GS; Bates J; Livermore DM
    Lancet; 1998 Aug; 352(9127):546-7. PubMed ID: 9716067
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP; Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y; Yu XH; Wang R; An MM; Liang BB
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
    Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates.
    Kamer AMA; El Maghraby GM; Shafik MM; Al-Madboly LA
    BMC Microbiol; 2024 Jul; 24(1):277. PubMed ID: 39060955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
    Drenjancević D; Vranes J; Bedenić B; Sakić-Zdravcević K
    Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biofilm formation and antibiotic resistance pattern of Pseudomonas aeruginosa in human and environmental isolates.
    Gholami S; Tabatabaei M; Sohrabi N
    Microb Pathog; 2017 Aug; 109():94-98. PubMed ID: 28549926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.
    Humphries RM; Hindler JA; Wong-Beringer A; Miller SA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
    Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
    J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
    Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
    J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
    Badawy MSEM; Elkhatib WF; Shebl RI
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):53. PubMed ID: 37394468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase.
    Bagge N; Ciofu O; Skovgaard LT; Høiby N
    APMIS; 2000 Sep; 108(9):589-600. PubMed ID: 11110047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.
    Feng Y; Jonker MJ; Moustakas I; Brul S; Ter Kuile BH
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4229-36. PubMed ID: 27139485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa persister cell formation upon antibiotic exposure in planktonic and biofilm state.
    Patel H; Buchad H; Gajjar D
    Sci Rep; 2022 Sep; 12(1):16151. PubMed ID: 36168027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae.
    Panáček A; Smékalová M; Večeřová R; Bogdanová K; Röderová M; Kolář M; Kilianová M; Hradilová Š; Froning JP; Havrdová M; Prucek R; Zbořil R; Kvítek L
    Colloids Surf B Biointerfaces; 2016 Jun; 142():392-399. PubMed ID: 26970828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.